Cargando…
Clopidogrel Resistance Is Associated With DNA Methylation of Genes From Whole Blood of Humans
Antiplatelet therapy has become a cornerstone in the treatment of coronary heart disease (CHD). However, due to high-residual-platelet-reactivity, clopidogrel resistance (CR) is a common phenomenon, and it is rarely known about the relationship between CR and epigenetic changes. This study compared...
Autores principales: | Yang, Jin, Yu, Qinglin, Xu, Zhifeng, Zheng, Nan, Zhong, Jinyan, Li, Jiyi, Liu, Yahui, Xu, Hongyu, Su, Jia, Ji, Lindan, Chen, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844369/ https://www.ncbi.nlm.nih.gov/pubmed/33519892 http://dx.doi.org/10.3389/fgene.2020.583215 |
Ejemplares similares
-
Associations of PER3 polymorphisms with clopidogrel resistance among Chinese Han people treated with clopidogrel
por: Zheng, Nan, et al.
Publicado: (2021) -
Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease
por: Su, Jia, et al.
Publicado: (2019) -
Association of P2Y12 Gene Promoter DNA Methylation with the Risk of Clopidogrel Resistance in Coronary Artery Disease Patients
por: Su, Jia, et al.
Publicado: (2014) -
The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population
por: Su, Jia, et al.
Publicado: (2017) -
DNA methylation profile in the whole blood of acute coronary syndrome patients with aspirin resistance
por: Yu, Qinglin, et al.
Publicado: (2022)